VARIVAX is a Subcutaneous Injection, Powder, Lyophilized, For Suspension in the Vaccine category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Varicella-zoster Virus Strain Oka/merck Live Antigen.
Product ID | 0006-4827_325565a6-7cd4-49e9-a628-fa338c0f7d0e |
NDC | 0006-4827 |
Product Type | Vaccine |
Proprietary Name | VARIVAX |
Generic Name | Varicella Virus Vaccine Live |
Dosage Form | Injection, Powder, Lyophilized, For Suspension |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 1995-03-17 |
Marketing Category | BLA / BLA |
Application Number | BLA103552 |
Labeler Name | Merck Sharp & Dohme Corp. |
Substance Name | VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN |
Active Ingredient Strength | 1350 [PFU]/.5mL |
Pharm Classes | Live Attenuated Varicella Zoster Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [CS],Chickenpox Vaccine [CS],Live Attenuated Herpes Zoster Virus Vaccine [EPC],Herpes Zoster Vaccine [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 1995-03-17 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA103552 |
Product Type | VACCINE |
Billing Unit | EA |
Marketing Start Date | 1995-03-17 |
Marketing Category | BLA |
Application Number | BLA103552 |
Product Type | VACCINE |
Billing Unit | EA |
Marketing Start Date | 2013-01-17 |
Ingredient | Strength |
---|---|
VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN | 1350 [PFU]/.5mL |
NDC | Brand Name | Generic Name |
---|---|---|
0006-4826 | VARIVAX | Varicella Virus Vaccine Live |
0006-4827 | VARIVAX | Varicella Virus Vaccine Live |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
VARIVAX 73509696 1340022 Live/Registered |
MERCK & CO., INC. 1984-11-19 |